Article
Prognostic implications of myelodysplasia-related gene mutations in NPM1-mutated acute myeloid leukemia: a systematic review and meta-analysis.
Haematologica - 1 Sept 2026
Chang Yu-Sung, Lee Yi-Wei, Liu Chieh-Yu, Othman Jad, Eckardt Jan-Niklas, Zhou Qianghua, Tien Feng-Ming, Lyu Ting-Wei, Tsai Xavier Cheng-Hong, Lin Chien-Chin, Chang Hong, Ko Bor-Sheng, Chou Wen-Chien, Röllig Christoph, Russell Nigel, Dillon Richard, Hou Hsin-An
Abstract excerpt
NPM1-mutated (NPM1mut) acute myeloid leukemia (AML) is generally classified as favorable-risk under the 2022 European LeukemiaNet (ELN-2022) guidelines, except in the presence of FLT3-internal tandem duplication or adverse-risk cytogenetics. However, the prognostic significance of co-occurring myelodysplasia-related gene (MRG) mutations remains unclear, with prior studies yielding inconsistent results. To clarify...
Read the complete abstract on PubMedTopics
- Humans
- Nucleophosmin
- Mutation
- Leukemia, Myeloid, Acute
- Prognosis
